Back to Search

MARC TAKEMOTO, PHARM.D.

PHARM.D.

Oncology Pharmacist

NPI: 1811060239Individual

Specialties, Licenses & Credentials

Oncology PharmacistPrimary

Pharmacist — Oncology

Code: 1835X0200X

2261(HI)

Research & Publications (20)

Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
PMID 19114027·Biochem Biophys Res Commun·2009
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3288 MOANALUA RD
HONOLULU, HI 96819

Quick Facts

NPI
1811060239
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile